BDBM752329 (1R,2S,5S)-3-(2-(3-acetyl- 7-methyl-5-(2-methylpyr- azolo[1,5-a]pyrimidin-6- yl)-1H-indol-1-yl)acetyl)- N-(3-(methoxymethyl)-6- (trifluoromethyl)pyridin-2- yl)-3-azabicyclo[3.1.0] hexane-2-carboxamide::US20250197403, Compound 7

SMILES COCc1ccc(C(F)(F)F)nc1NC(=O)[C@@H]1[C@@H]2C[C@@H]2CN1C(=O)Cn1cc(C(C)=O)c2cc(-c3cnc4cc(C)nn4c3)cc(C)c21

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 752329   

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM752329((1R,2S,5S)-3-(2-(3-acetyl- 7-methyl-5-(2-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent